Women’s Hormone-Driven Heart Risk Panel
A comprehensive women’s hormone-driven heart risk panel evaluating cortisol, DHEA-S, estradiol, progesterone, FSH, LH, testosterone, SHBG, full thyroid function with antibodies, glucose, and insulin. Designed to assess how adrenal, ovarian, thyroid, and metabolic hormones influence cardiovascular and cardiometabolic health during hormonal transitions.
- $1,504.98
- $369
- Save: 75.48%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Cortisol AM
Cortisol, A.M.
Also known as: Dehydroepiandrosterone Sulfate, DHEA SO4, DHEA Sulfate Immunoassay, DHEAS, Transdehydroandrosterone
DHEA SULFATE
Estradiol
Also known as: Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH), Follicle Stimulating Hormone and Luteinizing Hormone
Fsh
Lh
Glucose
Also known as: Insulin (fasting)
Insulin
Also known as: Progesterone Immunoassay
Progesterone
Also known as: Reverse T3, Reverse Triiodothyronine, RT3, T3 Reverse RT3 LCMSMS, Triiodothyronine Reverse
T3 Reverse, LC/MS/MS
Also known as: Free T3, FT3, T3 Free
T3, Free
Also known as: Free T4, FT4, T4 Free
T4, Free
Also known as: Testosterone Total And Free And Sex Hormone Binding Globulin
Free Testosterone
Sex Hormone Binding
TESTOSTERONE, TOTAL,
Thyroglobulin Antibodies
Thyroid Peroxidase
Also known as: Thyroid Stimulating Hormone Test, Thyrotropin Test
TSH
The Women’s Hormone-Driven Heart Risk Panel panel contains 13 tests with 17 biomarkers .
Evaluating the Hormonal Drivers of Cardiometabolic Risk in Women
The Women’s Hormone-Driven Heart Risk Panel is a comprehensive laboratory assessment designed to evaluate how hormonal balance influences cardiovascular and metabolic health in women. Hormones play a central role in regulating lipid metabolism, insulin sensitivity, vascular tone, inflammation, stress response, and body composition. Shifts in reproductive, adrenal, thyroid, and metabolic hormones can significantly impact long-term heart health.
This panel integrates adrenal hormones (Cortisol AM and DHEA-S), ovarian hormones (Estradiol, Progesterone), pituitary signaling hormones (FSH and LH), androgen markers (Total and Free Testosterone, Sex Hormone Binding Globulin), comprehensive thyroid function testing (TSH, Free T4, Free T3, Reverse T3, Thyroid Peroxidase Antibodies, Thyroglobulin Antibodies), and metabolic markers (Glucose and Insulin). Together, these biomarkers provide a multidimensional evaluation of endocrine pathways that influence cardiometabolic risk.
Hormonal transitions such as perimenopause and menopause are associated with changes in body fat distribution, insulin resistance, lipid levels, and vascular function. Thyroid dysfunction, adrenal imbalance, and androgen shifts may further modify cardiovascular risk factors. By evaluating these systems together, this panel helps create a clearer understanding of how endocrine function intersects with metabolic and cardiovascular health.
Rather than focusing solely on cholesterol values, this hormone-focused cardiovascular panel explores upstream drivers that can affect lipid metabolism, glucose regulation, inflammatory signaling, and vascular health. It is designed to support informed discussions between patients and healthcare providers about hormone-related influences on cardiometabolic patterns and overall heart risk assessment.
When and Why Someone Would Order This Panel
Hormonal Changes and Cardiovascular Risk
Women may consider the Women’s Hormone-Driven Heart Risk Panel when experiencing hormonal transitions that may influence metabolic or cardiovascular patterns. Perimenopause, menopause, and postmenopause are associated with shifts in estrogen, progesterone, and androgen balance. These changes may affect lipid metabolism, insulin sensitivity, vascular tone, and inflammatory responses.
This panel may be appropriate for women who:
-
Are experiencing irregular cycles or menopausal symptoms
-
Have changes in weight distribution or metabolic patterns
-
Have a history of thyroid dysfunction or autoimmune thyroid disease
-
Are monitoring cardiometabolic risk in the context of hormonal changes
-
Have elevated glucose or insulin levels
-
Want to understand how endocrine balance may influence heart health
Evaluation of Thyroid and Autoimmune Influence
Thyroid hormones directly impact cholesterol metabolism, heart rate, vascular resistance, and energy utilization. Even subtle thyroid dysfunction can influence lipid levels and insulin sensitivity. The inclusion of thyroid antibodies (TPO and Thyroglobulin antibodies) allows evaluation of autoimmune thyroid conditions that may affect long-term metabolic and cardiovascular outcomes.
Assessment of Stress and Adrenal Function
Chronic stress and altered cortisol rhythms may contribute to insulin resistance, abdominal fat accumulation, and metabolic changes. Measuring Cortisol AM and DHEA-S helps assess adrenal signaling patterns that may influence cardiometabolic risk.
Insulin Resistance and Metabolic Regulation
Elevated insulin levels or impaired glucose regulation are closely associated with cardiovascular disease risk. By including fasting Glucose and Insulin, this panel helps evaluate early patterns of insulin resistance that may precede more overt metabolic dysfunction.
Overall, this panel may be ordered as part of a comprehensive evaluation of hormone-related influences on cardiometabolic health, especially during times of endocrine transition.
What Does the Panel Measure?
Adrenal Hormones
-
Cortisol AM: Reflects morning adrenal cortisol production and stress response signaling.
-
DHEA-S (Dehydroepiandrosterone Sulfate): An adrenal androgen precursor involved in hormone balance and metabolic regulation.
Ovarian and Pituitary Hormones
-
Estradiol: Primary estrogen influencing vascular function, lipid metabolism, and reproductive health.
-
Progesterone: Hormone involved in menstrual cycle regulation and hormonal balance.
-
FSH (Follicle-Stimulating Hormone) and LH (Luteinizing Hormone): Pituitary hormones that regulate ovarian function and help determine reproductive stage.
Androgen Markers
-
Testosterone (Free and Total): Androgen levels that influence body composition, energy, and metabolic patterns.
-
Sex Hormone Binding Globulin (SHBG): Protein that binds sex hormones and affects bioavailability.
Thyroid Function and Autoimmune Markers
-
TSH (Thyroid-Stimulating Hormone): Regulates thyroid hormone production.
-
Free T4 and Free T3: Active circulating thyroid hormones.
-
Reverse T3: Inactive thyroid hormone metabolite that may reflect altered conversion patterns.
-
Thyroid Peroxidase Antibodies (TPOAb) and Thyroglobulin Antibodies (TgAb): Markers associated with autoimmune thyroid conditions.
Metabolic Markers
-
Glucose: Measures fasting blood sugar levels.
-
Insulin: Assesses insulin production and may help evaluate insulin resistance when interpreted alongside glucose.
Together, these biomarkers provide a comprehensive view of endocrine pathways that influence cardiovascular and metabolic health.
How Patients and Healthcare Providers Use the Results
Understanding Hormone-Related Cardiometabolic Patterns
Healthcare providers may use the results of this panel to evaluate how hormonal imbalances influence cardiometabolic markers. For example, declining estradiol during menopause may be associated with changes in lipid patterns and body fat distribution. Elevated insulin levels alongside normal glucose may suggest early insulin resistance.
Identifying Thyroid Dysfunction
Abnormal TSH, Free T4, or Free T3 levels may indicate hypothyroidism or hyperthyroidism. Positive thyroid antibodies may suggest autoimmune thyroid conditions such as Hashimoto’s thyroiditis or Graves’ disease. Because thyroid dysfunction can affect cholesterol and metabolic health, identifying these patterns is clinically important.
Evaluating Androgen Balance
Altered free or total testosterone levels, especially when interpreted alongside SHBG, may influence metabolic patterns and insulin sensitivity. These results may help identify hormonal contributors to cardiometabolic risk.
Assessing Adrenal and Stress Response Patterns
Abnormal cortisol or DHEA-S levels may indicate altered stress response signaling, which can influence glucose metabolism, body composition, and cardiovascular risk factors.
Supporting Preventive Monitoring
This panel may be used for baseline evaluation or ongoing monitoring during hormonal transitions. By understanding how endocrine pathways intersect with metabolic regulation, healthcare providers can better contextualize cardiovascular risk factors and guide evidence-based health planning.
A Hormone-Centered Perspective on Women’s Heart Risk
The Women’s Hormone-Driven Heart Risk Panel offers a comprehensive evaluation of endocrine pathways that influence cardiovascular and metabolic health. By examining adrenal hormones, reproductive hormones, thyroid function, androgen balance, and insulin signaling together, this panel provides a broader perspective on heart risk factors beyond traditional lipid testing alone.
Hormonal balance plays a critical role in regulating metabolism, vascular health, glucose control, and inflammatory responses. During life transitions such as perimenopause and menopause, understanding these shifts becomes especially important.
Through integrated hormone and metabolic biomarker assessment, this panel supports informed discussions between women and their healthcare providers. It provides a data-driven foundation for evaluating how endocrine function may contribute to cardiometabolic patterns, helping guide personalized monitoring and long-term cardiovascular wellness strategies grounded in objective laboratory insights.